INFU: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	4,591	2,332
Provision for doubtful accounts	102	39
Depreciation	9,236	6,166
Loss on disposal of and reserve adjustments for medical equipment	337	380
Gain on sale of medical equipment	2,282	1,723
Amortization of intangible assets	709	495
Amortization of deferred debt issuance costs	61	39
Stock-based compensation	3,091	1,769
Deferred income taxes	2,530	1,363
Accounts receivable	2,167	2,089
Inventories	-941	-863
Other current assets	762	-24
Other assets	-1,028	-1,106
Accounts payable and other liabilities	-133	-1,975
Net cash provided by operating activities	17,282	8,789
Acquisition of business	1,412	1,412
Purchase of medical equipment	5,341	4,314
Purchase of property and equipment	427	348
Proceeds from sale of medical equipment, property and equipment	2,582	1,728
Net cash used in investing activities	-4,598	-4,346
Principal payments on long-term debt	44,265	30,261
Cash proceeds from long-term debt	41,502	32,717
Debt issuance costs	230	12
Common stock repurchased as part of share repurchase program	8,563	6,395
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans	1,036	458
Cash proceeds from exercise of options and espp	336	159
Net cash used in financing activities	-12,256	-4,250
Net change in cash and cash equivalents	428	193
Cash and cash equivalents at beginning of period	527	-
Cash and cash equivalents at end of period	955	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

INFU: the cashflow